These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2307540)

  • 1. Differences in c-myc and pvt-1 amplification in SEWA sarcoma sublines selected for adherent or non-adherent growth.
    Minarovits J; Steinitz M; Boldog F; Imreh S; Wirschubsky Z; Ingvarsson S; Hedenskog M; Minarovits-Kormuta S; Klein G
    Int J Cancer; 1990 Mar; 45(3):514-20. PubMed ID: 2307540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyoma DNA replication dependent upon growth condition of SEWA sarcoma cells.
    Robinson R; Ronai Z
    Mol Carcinog; 1990; 3(5):268-72. PubMed ID: 2173930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene amplification in the murine SEWA system.
    Levan G; Ståhl F; Wettergren Y
    Mutat Res; 1992 May; 276(3):285-90. PubMed ID: 1374520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is conversion of solid into more anoxic ascites tumors associated with p53 inactivation?
    Magnusson KP; Satalino R; Qian W; Klein G; Wiman KG
    Oncogene; 1998 Nov; 17(18):2333-7. PubMed ID: 9811464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of SEWA sarcoma cell proteins with the intracisternal A-type particle long terminal repeat DNA sequence.
    Ronai Z; Robinson R; Lee G; Okin E; Minarovits J; Wirchubsky Z; Klein G; Weinstein IB
    Mol Carcinog; 1992; 5(1):81-9. PubMed ID: 1543543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification and enhanced expression of the c-myc oncogene in mouse SEWA tumour cells.
    Schwab M; Ramsay G; Alitalo K; Varmus HE; Bishop JM; Martinsson T; Levan G; Levan A
    Nature; 1985 May 23-29; 315(6017):345-7. PubMed ID: 3889656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of MHC class I antigens is not a general mechanism for the increased tumorigenicity caused by c-myc amplification.
    Dahllöf B
    Oncogene; 1990 Mar; 5(3):433-5. PubMed ID: 2156210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of allelic preference in amplification and loss of the c-myc oncogene in methylcholanthrene-induced mouse sarcomas.
    Niwa O; Kominami R
    Jpn J Cancer Res; 1992 Nov; 83(11):1192-7. PubMed ID: 1483933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A splice donor site mutation results in the insertion of five extra amino acids into P53 from SEWA mouse sarcoma cells.
    Magnusson KP; Minarovits J; Klein G; Wiman KG
    Gene; 1995 Sep; 162(2):231-4. PubMed ID: 7557434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of minisatellite instability with c-myc amplification and K-ras mutation in methylcholanthrene-induced mouse sarcomas.
    Niwa O; Kamiya K; Furihata C; Nitta Y; Wang Z; Fan YJ; Ninomiya Y; Kotomura N; Numoto M; Kominami R
    Cancer Res; 1995 Dec; 55(23):5670-6. PubMed ID: 7585652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas.
    Watanabe H; Shimokado K; Asahara T; Dohi K; Niwa O
    Jpn J Cancer Res; 1999 Jan; 90(1):40-7. PubMed ID: 10076563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.
    Martinsson T; Ståhl F; Pollwein P; Wenzel A; Levan A; Schwab M; Levan G
    Oncogene; 1988 Oct; 3(4):437-41. PubMed ID: 3078951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ring-shaped double minutes in human acute myelocytic leukemia and in the murine SEWA sarcoma. A comparison.
    Marinello MJ; Levan A
    Hereditas; 1982; 96(1):39-48. PubMed ID: 6953058
    [No Abstract]   [Full Text] [Related]  

  • 14. Preferential accumulation of putative "dics" under non-selective conditions during in vivo progression of a murine ascites sarcoma.
    Huda R; Biswas T; Pal AK; Chakrabarti A; Chakrabarti S
    Folia Biol (Krakow); 1994; 42(1-2):57-61. PubMed ID: 7982508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate resistance and double minutes in a cell line from the SEWA mouse ascites tumor.
    Martinsson T; Tenning P; Lundh L; Levan G
    Hereditas; 1982; 97(1):123-37. PubMed ID: 7129936
    [No Abstract]   [Full Text] [Related]  

  • 16. Amplification and rearrangement of c-myc in radiation-induced murine osteosarcomas.
    Sturm SA; Strauss PG; Adolph S; Hameister H; Erfle V
    Cancer Res; 1990 Jul; 50(13):4146-53. PubMed ID: 2141296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal characteristics of the NK-Ly mouse ascites tumour passaged on AB-Jena-Gat.-Ko. strain mice.
    Seidlová A; Horák J
    Neoplasma; 1971; 18(1):19-26. PubMed ID: 5108369
    [No Abstract]   [Full Text] [Related]  

  • 18. [Marker chromosome study of murine cell line tumor tissues].
    Rodova MA; Mikhailova GR; Novokhatskiĭ AS
    Vopr Onkol; 1980; 26(2):54-7. PubMed ID: 6153826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
    Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.